Our Businesses

Targeted Interventions Improve the Quality of Behavioral Drug Prescribing

Our analysis of over 11 million pharmacy claims reveals that over 70% of behavioral health drugs are prescribed by providers who have little or no training in behavioral health.  Over 30% of those prescriptions fall outside evidence-based prescribing guidelines.

Magellan partners with both behavioral health providers and primary care physicians to improve the quality of behavioral health pharmaceutical prescribing practices in order to maximize clinical outcomes and reduce behavioral health drug spending.

Features:

• Evidence-based prescribing guidelines
• Drug claim data analytics employing over 100 clinical algorithms to produce patient and provider-specific reports which define the scope of and targets for improvement
• Collaboration with providers prescribing outside of best practices related to issues such as duplicate prescriptions, excess dosing, and addictive pain agents to provide education and information to maximize compliance